Medical Weight Loss for Carrollton, Texas Residents

Carrollton, Texas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Carrollton through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Carrollton patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for Texas residents. Doctor review just $119 (medication separate).

Why Carrollton Residents Choose New Hope Weight Loss

What draws a lot of Carrollton patients to New Hope is the honest pricing. Semaglutide starts at $166 a month and tirzepatide at $233 a month, with a $119 physician visit, and that is the whole conversation. There is no surprise line item, no distance surcharge for living outside Costa Mesa, and no pressure to buy a bundle you did not ask for. You see the real numbers before you commit, which is how it should be.

Medical weight loss for Carrollton is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

If you are searching for a weight-loss physician in Carrollton, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts Texas patients exactly where local ones are. We care for patients throughout downtown Carrollton and the greater Dallas metro area. A licensed care coordinator stays reachable by message and phone, so help is a few taps away anywhere in Texas.

By handling visits through telehealth, we serve every neighborhood in Carrollton, from downtown Carrollton and the greater Dallas metro area, without asking anyone to travel. Patients anywhere in Texas, including the downtown Carrollton and the greater Dallas metro area neighborhoods, get the same pricing because care is delivered by telehealth from our Costa Mesa clinic. Texas is one of the largest and fastest-growing states in the country, and New Hope Weight Loss serves patients all across it by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Carrollton telehealth patients.

How Telehealth Works for Carrollton

No waiting rooms, no commute across Carrollton traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Carrollton home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Carrollton

Where is the New Hope Weight Loss location serving Carrollton?

The location serving Carrollton is our Costa Mesa, California clinic, which is our only physical site. We care for Carrollton, Texas patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Carrollton patients?

It is the standard for Carrollton. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Carrollton in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Carrollton patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Carrollton patients.

What areas of Carrollton do you serve?

We serve patients from across Carrollton by telehealth, including downtown Carrollton and the greater Dallas metro area.

What does treatment cost for Carrollton patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Carrollton.

Carrollton Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Carrollton, Texas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.